youtu.be/4YRNbpocb2E
✨ Proud to have been part of this short video, and I hope it inspires you too! ✨
Every step forward brings us closer to a future where cancer is no longer a threat.
Let’s keep pushing the boundaries of science and innovation! 💙🔬 #CancerResearch #TheICR
✨ Proud to have been part of this short video, and I hope it inspires you too! ✨
Every step forward brings us closer to a future where cancer is no longer a threat.
Let’s keep pushing the boundaries of science and innovation! 💙🔬 #CancerResearch #TheICR
How your company can make a difference
YouTube video by The Institute of Cancer Research, London
youtu.be
March 12, 2025 at 2:28 PM
youtu.be/4YRNbpocb2E
✨ Proud to have been part of this short video, and I hope it inspires you too! ✨
Every step forward brings us closer to a future where cancer is no longer a threat.
Let’s keep pushing the boundaries of science and innovation! 💙🔬 #CancerResearch #TheICR
✨ Proud to have been part of this short video, and I hope it inspires you too! ✨
Every step forward brings us closer to a future where cancer is no longer a threat.
Let’s keep pushing the boundaries of science and innovation! 💙🔬 #CancerResearch #TheICR
A heartfelt thank you for making our retreat such an amazing , meaningful,warm, fun, and learning experience !!
you continue to inspire me !
Special thank you to the creative and fun
Alejandro Allo Anido @emilia.chen
And all for coming
you continue to inspire me !
Special thank you to the creative and fun
Alejandro Allo Anido @emilia.chen
And all for coming
March 6, 2025 at 9:50 PM
A heartfelt thank you for making our retreat such an amazing , meaningful,warm, fun, and learning experience !!
you continue to inspire me !
Special thank you to the creative and fun
Alejandro Allo Anido @emilia.chen
And all for coming
you continue to inspire me !
Special thank you to the creative and fun
Alejandro Allo Anido @emilia.chen
And all for coming
Our work out there now! A big thank you again and forever to everyone who made this possible, especially to the leading author
#Abigail.Shea and to the patients!
aacrjournals.org/cancerres/ar...
see also: www.linkedin.com/posts/alejan...
#Abigail.Shea and to the patients!
aacrjournals.org/cancerres/ar...
see also: www.linkedin.com/posts/alejan...
Modeling Drug Responses and Evolutionary Dynamics Using Patient-Derived Xenografts Reveals Precision Medicine Strategies for Triple-Negative Breast Cancer
Patient-derived tumor xenografts from treatment-naïve breast cancer samples can predict patient drug responses and model treatment-induced phenotypic and functional evolution, making them valuable pre...
aacrjournals.org
February 11, 2025 at 2:33 PM
Our work out there now! A big thank you again and forever to everyone who made this possible, especially to the leading author
#Abigail.Shea and to the patients!
aacrjournals.org/cancerres/ar...
see also: www.linkedin.com/posts/alejan...
#Abigail.Shea and to the patients!
aacrjournals.org/cancerres/ar...
see also: www.linkedin.com/posts/alejan...
Our breast cancer PDX paper out in Cancer Research
Breast cancer PDXs can predict patient drug responses, and model phenotypic and functional cancer evolution.
Full text available: lnkd.in/eDNN_gpQ
Breast cancer PDXs can predict patient drug responses, and model phenotypic and functional cancer evolution.
Full text available: lnkd.in/eDNN_gpQ
Modeling Drug Responses and Evolutionary Dynamics using Patient-Derived Xenografts Reveals Precision Medicine Strategies for Triple Negative Breast Cancer
Abstract. The inter- and intra-tumor heterogeneity of triple negative breast cancers (TNBC), which is reflected in diverse drug responses, interplays with tumor evolution. Here, we developed a preclin...
aacrjournals.org
November 21, 2024 at 1:30 PM
Our breast cancer PDX paper out in Cancer Research
Breast cancer PDXs can predict patient drug responses, and model phenotypic and functional cancer evolution.
Full text available: lnkd.in/eDNN_gpQ
Breast cancer PDXs can predict patient drug responses, and model phenotypic and functional cancer evolution.
Full text available: lnkd.in/eDNN_gpQ